Unintended insulin delivery using Omnipod DASH during a high-altitude flight.
Contraindications and precautions
Diabetes
Drugs: endocrine system
Medical consequences of conflict
Journal
BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291
Informations de publication
Date de publication:
21 Mar 2022
21 Mar 2022
Historique:
pmc-release:
21
03
2024
entrez:
22
3
2022
pubmed:
23
3
2022
medline:
24
3
2022
Statut:
epublish
Résumé
Insulin pumps are an important tool in the management of type I diabetes mellitus. Omnipod DASH is a tubeless insulin pump that delivers insulin through customisable basal rate and bolus amounts. There is no data available to date on how this insulin pump delivery system is influenced by changes in atmospheric pressure during flight at high altitudes. We report a case of a 55-year-old woman who developed symptomatic hypoglycaemia while using this pump during flight in a non-pressurised cabin. This report demonstrates the risk of insulin pump therapy at high altitudes. Flight emergencies involving rapid depressurisation may lead to catastrophic hypoglycaemia. Caution should be exercised when using insulin pump therapy during flights and manual insulin delivery should be considered.
Identifiants
pubmed: 35314435
pii: 15/3/e247138
doi: 10.1136/bcr-2021-247138
pmc: PMC8938693
pii:
doi:
Substances chimiques
Insulin
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Aviat Space Environ Med. 2008 Apr;79(4):433-9
pubmed: 18457303
Diabetes Care. 2011 Sep;34(9):1932-3
pubmed: 21816978
Diabetes Technol Ther. 2017 Apr;19(4):265-268
pubmed: 28231029